All In MedTech

Device Trial Radar · NCT07931482

Revitalis - Midface (Cheek Area)

A Prospective, Open-Label, Single-Arm Clinical Study to Evaluate the Effects and Safety of Croma Revitalis for Improvement of Midface (Cheek Area) Skin Smoothness

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Nov 4, 2026

Primary completion

Oct 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Croma-Pharma GmbHNot on our public-company list
Sponsor type
Industry
First posted
Nov 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the effects and safety of croma revitalis in improving midface (cheek area) skin smoothness

Conditions

  • Skin Smoothness

Interventions

  • Croma revitalisDevice

    Croma revitalis is a hyaluronic acid-based injectable gel for soft tissue implantation and intradermal aesthetic use. 1 mL per cheek side per treatment session, distributed across 4 intradermal injection points (0.25 mL each) using a standardized injection technique with a sterile needle at baseline Week 0, Week 3, and Week 6. After week 6 a follow up period until week 30 is performed at week 9, 12, 16, 20, 24 and 30.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Skin Smoothness: Responder status assessed by independent evaluator at siteTime frame: week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yuvell

    Vienna, Austria · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.